<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35406813</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1246</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11071246</ELocationID><Abstract><AbstractText>Little is known about the early pathogenic events by which mutant superoxide dismutase 1 (SOD1) causes amyotrophic lateral sclerosis (ALS). This lack of mechanistic understanding is a major barrier to the development and evaluation of efficient therapies. Although protein aggregation is known to be involved, it is not understood how mutant SOD1 causes degeneration of motoneurons (MNs). Previous research has relied heavily on the overexpression of mutant SOD1, but the clinical relevance of SOD1 overexpression models remains questionable. We used a human induced pluripotent stem cell (iPSC) model of spinal MNs and three different endogenous ALS-associated <i>SOD1</i> mutations (D90A<sup>hom</sup>, R115G<sup>het</sup> or A4V<sup>het</sup>) to investigate early cellular disturbances in MNs. Although enhanced misfolding and aggregation of SOD1 was induced by proteasome inhibition, it was not affected by activation of the stress granule pathway. Interestingly, we identified loss of mitochondrial, but not lysosomal, integrity as the earliest common pathological phenotype, which preceded elevated levels of insoluble, aggregated SOD1. A super-elongated mitochondrial morphology with impaired inner mitochondrial membrane potential was a unifying feature in mutant SOD1 iPSC-derived MNs. Impaired mitochondrial integrity was most prominent in mutant D90A<sup>hom</sup> MNs, whereas both soluble disordered and detergent-resistant misfolded SOD1 was more prominent in R115G<sup>het</sup> and A4V<sup>het</sup> mutant lines. Taking advantage of patient-specific models of SOD1-ALS in vitro, our data suggest that mitochondrial dysfunction is one of the first crucial steps in the pathogenic cascade that leads to SOD1-ALS and also highlights the need for individualized medical approaches for SOD1-ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0329-5644</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Carl Gustav Carus Dresden, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pal</LastName><ForeName>Arun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Carl Gustav Carus Dresden, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dresden High Magnetic Field Laboratory (HLD), Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Integrative Medical Biology, Ume&#xe5; University, 90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimyanin</LastName><ForeName>Vitaly L</ForeName><Initials>VL</Initials><Identifier Source="ORCID">0000-0001-8601-4451</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Carl Gustav Carus Dresden, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liehr</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Carl Gustav Carus Dresden, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Neubeck</LastName><ForeName>Cl&#xe4;re</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2955-1626</Identifier><AffiliationInfo><Affiliation>German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), 69192 Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OncoRay-National Center for Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic for Particle Therapy, West German Proton Therapy Centre Essen (WPE) gGmbH, University Medical Centre of Essen, 45147 Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krause</LastName><ForeName>Mechthild</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), 69192 Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OncoRay-National Center for Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology-OncoRay, 01328 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiotherapy and Radiation Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Tumor Diseases (NCT), Partner Site Dresden, University Hospital Carl Gustav Carus Dresden, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parab</LastName><ForeName>Mrudula G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Carl Gustav Carus Dresden, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalmbach</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marklund</LastName><ForeName>Stefan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Clinical Chemistry, Ume&#xe5; University, 90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterneckert</LastName><ForeName>Jared</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7688-3124</Identifier><AffiliationInfo><Affiliation>Center for Regenerative Therapies Dresden, Technical University Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munch Andersen</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Ume&#xe5; University, 90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegner</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilthorpe</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0002-6884-4774</Identifier><AffiliationInfo><Affiliation>Department of Integrative Medical Biology, Ume&#xe5; University, 90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Translational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS1</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">axonal trafficking</Keyword><Keyword MajorTopicYN="N">live cell imaging</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword></KeywordList><CoiStatement>A.H. has received personal fees and non-financial support from Biogen and Desitin during the conduct of the study outside of the submitted work. R.G. has received honoraria from Biogen as an advisory board member and for lectures and as a consultant and advisory board member from Hoffmann-La Roche. He also received travel expenses and research support from Biogen. M.K. Krause received funding for her research projects by IBA (2016), Merck KGaA (2014&#x2013;2018 for preclinical study; 2018&#x2013;2020 for clinical study), Medipan GmbH (2014&#x2013;2018). She is involved in an ongoing publicly funded (German Federal Ministry of Education and Research) project with the companies Medipan, Attomol GmbH, GA Generic Assays GmbH, Gesellschaft f&#xfc;r medizinische und wissenschaftliche genetische Analysen, Lipotype GmbH and PolyAn GmbH (2019&#x2013;2021). For the present study, M.K. Krause confirms that none of the above mentioned funding sources were involved.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35406813</ArticleId><ArticleId IdType="pmc">PMC8997900</ArticleId><ArticleId IdType="doi">10.3390/cells11071246</ArticleId><ArticleId IdType="pii">cells11071246</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O., Powell J.F., Andersen P.M., Al-Chalabi A. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum. Mutat. 2012;33:1345&#x2013;1351. doi: 10.1002/humu.22157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22157</ArticleId><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Nilsson P., Keranen M.L., Forsgren L., Hagglund J., Karlsborg M., Ronnevi L.O., Gredal O., Marklund S.L. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Pt 10Brain J. Neurol. 1997;120:1723&#x2013;1737. doi: 10.1093/brain/120.10.1723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/120.10.1723</ArticleId><ArticleId IdType="pubmed">9365366</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Forsgren L., Binzer M., Nilsson P., Ala-Hurula V., Keranen M.L., Bergmark L., Saarinen A., Haltia T., Tarvainen I., et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Pt 4Brain J. Neurol. 1996;119:1153&#x2013;1172. doi: 10.1093/brain/119.4.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.4.1153</ArticleId><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Nilsson P., Ala-Hurula V., Keranen M.L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L., Marklund S.L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat. Genet. 1995;10:61&#x2013;66. doi: 10.1038/ng0595-61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0595-61</ArticleId><ArticleId IdType="pubmed">7647793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bali T., Self W., Liu J., Siddique T., Wang L.H., Bird T.D., Ratti E., Atassi N., Boylan K.B., Glass J.D., et al. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. J. Neurol. Neurosurg. Psychiatry. 2017;88:99&#x2013;105. doi: 10.1136/jnnp-2016-313521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313521</ArticleId><ArticleId IdType="pmc">PMC5136332</ArticleId><ArticleId IdType="pubmed">27261500</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrikios J.S., Marie P. Diploma Thesis. Universit&#xe9; de Paris; Paris, France: 1918. Contribution &#xe0; l&#x2019;&#xe9;tude des Formes Cliniques et de l&#x2019;anatomie Pathologique de la Scl&#xe9;rose Lat&#xe9;rale Amyotrophique: &#xe9;tude Clinique de 21 cas de Scl&#xe9;rose Lat&#xe9;rale Amyotrophique dont 5 avec Autopsie.</Citation></Reference><Reference><Citation>Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003;552:335&#x2013;344. doi: 10.1113/jphysiol.2003.049478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2003.049478</ArticleId><ArticleId IdType="pmc">PMC2343396</ArticleId><ArticleId IdType="pubmed">14561818</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2017;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Indo H.P., Yen H.C., Nakanishi I., Matsumoto K., Tamura M., Nagano Y., Matsui H., Gusev O., Cornette R., Okuda T., et al. A mitochondrial superoxide theory for oxidative stress diseases and aging. J. Clin. Biochem. Nutr. 2015;56:1&#x2013;7. doi: 10.3164/jcbn.14-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.14-42</ArticleId><ArticleId IdType="pmc">PMC4306659</ArticleId><ArticleId IdType="pubmed">25834301</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G.H., Kim J.E., Rhie S.J., Yoon S. The Role of Oxidative Stress in Neurodegenerative Diseases. Exp. Neurobiol. 2015;24:325&#x2013;340. doi: 10.5607/en.2015.24.4.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.4.325</ArticleId><ArticleId IdType="pmc">PMC4688332</ArticleId><ArticleId IdType="pubmed">26713080</ArticleId></ArticleIdList></Reference><Reference><Citation>Said Ahmed M., Hung W.Y., Zu J.S., Hockberger P., Siddique T. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1. J. Neurol. Sci. 2000;176:88&#x2013;94. doi: 10.1016/S0022-510X(00)00317-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00317-8</ArticleId><ArticleId IdType="pubmed">10930589</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzardini M., Mangolini A., Lupi M., Ubezio P., Bendotti C., Cantoni L. Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells. J. Neurol. Sci. 2005;232:95&#x2013;103. doi: 10.1016/j.jns.2005.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.004</ArticleId><ArticleId IdType="pubmed">15850589</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D. Edaravone: A new drug approved for ALS. Cell. 2017;171:725. doi: 10.1016/j.cell.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.011</ArticleId><ArticleId IdType="pubmed">29100067</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I., Birve A., Berdynski M., Hjertkvist K., Rofougaran R., Nilsson T.K., Glass J.D., Marklund S.L., Andersen P.M. Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relatives. Amyotroph. Lateral Scler. Front. Degener. 2017;18:457&#x2013;463. doi: 10.1080/21678421.2017.1301481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1301481</ArticleId><ArticleId IdType="pubmed">28325066</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.H., Elpers C., Reunert J., McCormick M.L., Mohr J., Biskup S., Schwartz O., Rust S., Gruneberg M., Seelhofer A., et al. SOD1 deficiency: A novel syndrome distinct from amyotrophic lateral sclerosis. Brain J. Neurol. 2019;142:2230&#x2013;2237. doi: 10.1093/brain/awz182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz182</ArticleId><ArticleId IdType="pmc">PMC6658856</ArticleId><ArticleId IdType="pubmed">31332433</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Nordstrom U., Tsiakas K., Johannsen J., Volk A.E., Bierhals T., Zetterstrom P., Marklund S.L., Hempel M., Santer R. Phenotype in an Infant with SOD1 Homozygous Truncating Mutation. N. Engl. J. Med. 2019;381:486&#x2013;488. doi: 10.1056/NEJMc1905039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1905039</ArticleId><ArticleId IdType="pubmed">31314961</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Chapman A.L., Tennant M.E., Manser C., Tudor E.L., Lau K.F., Brownlees J., Ackerley S., Shaw P.J., McLoughlin D.M., et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 2007;16:2720&#x2013;2728. doi: 10.1093/hmg/ddm226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm226</ArticleId><ArticleId IdType="pmc">PMC4516806</ArticleId><ArticleId IdType="pubmed">17725983</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., McDonald K.K., Boukhedimi Y., McAlonis-Downes M., Lobsiger C.S., Bel Hadj S., Zandona A., Julien J.P., Shah S.B., Cleveland D.W. Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS ONE. 2011;6:e22031. doi: 10.1371/journal.pone.0022031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022031</ArticleId><ArticleId IdType="pmc">PMC3136936</ArticleId><ArticleId IdType="pubmed">21779368</ArticleId></ArticleIdList></Reference><Reference><Citation>Youle R.J., van der Bliek A.M. Mitochondrial fission, fusion, and stress. Science. 2012;337:1062&#x2013;1065. doi: 10.1126/science.1219855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1219855</ArticleId><ArticleId IdType="pmc">PMC4762028</ArticleId><ArticleId IdType="pubmed">22936770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Jeong S.Y., Lim W.C., Kim S., Park Y.Y., Sun X., Youle R.J., Cho H. Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence. J. Biol. Chem. 2007;282:22977&#x2013;22983. doi: 10.1074/jbc.M700679200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M700679200</ArticleId><ArticleId IdType="pubmed">17545159</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaasik A., Safiulina D., Choubey V., Kuum M., Zharkovsky A., Veksler V. Mitochondrial swelling impairs the transport of organelles in cerebellar granule neurons. J. Biol. Chem. 2007;282:32821&#x2013;32826. doi: 10.1074/jbc.M702295200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M702295200</ArticleId><ArticleId IdType="pubmed">17785462</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007;66:10&#x2013;16. doi: 10.1097/nen.0b013e31802c396b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31802c396b</ArticleId><ArticleId IdType="pubmed">17204932</ArticleId></ArticleIdList></Reference><Reference><Citation>Siklos L., Engelhardt J., Harati Y., Smith R.G., Joo F., Appel S.H. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann. Neurol. 1996;39:203&#x2013;216. doi: 10.1002/ana.410390210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390210</ArticleId><ArticleId IdType="pubmed">8967752</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., Gunther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman M.S., Trojanowski J.Q., Lee V.M. Neurodegenerative diseases: A decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 2004;10:1055&#x2013;1063. doi: 10.1038/nm1113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1113</ArticleId><ArticleId IdType="pubmed">15459709</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2004;27:723&#x2013;749. doi: 10.1146/annurev.neuro.27.070203.144244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144244</ArticleId><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., Takikawa M., Nakashima K., Hirano A., Cleveland D.W., Kusaka H., Shibata N., Kato M., Nakano I., Ohama E. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:163&#x2013;184. doi: 10.1080/14660820050515160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515160</ArticleId><ArticleId IdType="pubmed">11464950</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S. Amyotrophic lateral sclerosis models and human neuropathology: Similarities and differences. Acta Neuropathol. 2008;115:97&#x2013;114. doi: 10.1007/s00401-007-0308-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0308-4</ArticleId><ArticleId IdType="pubmed">18026741</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekhtiari Bidhendi E., Bergh J., Zetterstrom P., Forsberg K., Pakkenberg B., Andersen P.M., Marklund S.L., Brannstrom T. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis. Acta Neuropathol. 2018;136:939&#x2013;953. doi: 10.1007/s00401-018-1915-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1915-y</ArticleId><ArticleId IdType="pmc">PMC6280858</ArticleId><ArticleId IdType="pubmed">30284034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Fromholt S.E., O&#x2019;Neal V.M., Diamond J.H., Borchelt D.R. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol. 2016;131:103&#x2013;114. doi: 10.1007/s00401-015-1514-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1514-0</ArticleId><ArticleId IdType="pmc">PMC4699876</ArticleId><ArticleId IdType="pubmed">26650262</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandan R., Robison S.H., Munzer J.S., Bradley W.G. Deficient DNA repair in amyotrophic lateral sclerosis cells. J. Neurol. Sci. 1987;79:189&#x2013;203. doi: 10.1016/0022-510X(87)90272-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(87)90272-3</ArticleId><ArticleId IdType="pubmed">3112312</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Bordoni M., Diamanti L., Sproviero D., Gagliardi S., Cereda C. SOD1 in Amyotrophic Lateral Sclerosis: &#x201c;Ambivalent&#x201d; Behavior Connected to the Disease. Int. J. Mol. Sci. 2018;19:1345. doi: 10.3390/ijms19051345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051345</ArticleId><ArticleId IdType="pmc">PMC5983710</ArticleId><ArticleId IdType="pubmed">29751510</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang C.K., Liu Y., Thomas J., Zhang Y., Zheng X.F. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat. Commun. 2014;5:3446. doi: 10.1038/ncomms4446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4446</ArticleId><ArticleId IdType="pmc">PMC4678626</ArticleId><ArticleId IdType="pubmed">24647101</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujock M., Stanslowsky N., Bufler S., Naumann M., Reinhardt P., Sterneckert J., Kefalakes E., Kassebaum C., Bursch F., Lojewski X., et al. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells. Stem Cells. 2016;34:1563&#x2013;1575. doi: 10.1002/stem.2354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2354</ArticleId><ArticleId IdType="pubmed">26946488</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Gla&#xdf; H., Naumann M., Kreiter N., Japtok J., Sczech R., Hermann A. High content organelle trafficking enables disease state profiling as powerful tool for disease modelling. Sci. Data. 2018;5:180241. doi: 10.1038/sdata.2018.241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2018.241</ArticleId><ArticleId IdType="pmc">PMC6233479</ArticleId><ArticleId IdType="pubmed">30422121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursch F., Kalmbach N., Naujock M., Staege S., Eggenschwiler R., Abo-Rady M., Japtok J., Guo W., Hensel N., Reinhardt P., et al. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations. Hum. Mol. Genet. 2019;28:2835&#x2013;2850. doi: 10.1093/hmg/ddz107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz107</ArticleId><ArticleId IdType="pubmed">31108504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N., Pal A., Lojewski X., Corcia P., Naujock M., Reinhardt P., Sterneckert J., Petri S., Wegner F., Storch A., et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol. Dis. 2018;115:167&#x2013;181. doi: 10.1016/j.nbd.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Japtok J., Lojewski X., Naumann M., Klingenstein M., Reinhardt P., Sterneckert J., Putz S., Demestre M., Boeckers T.M., Ludolph A.C., et al. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol. Dis. 2015;82:420&#x2013;429. doi: 10.1016/j.nbd.2015.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.07.017</ArticleId><ArticleId IdType="pubmed">26253605</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P., Schmid B., Burbulla L.F., Schondorf D.C., Wagner L., Glatza M., Hoing S., Hargus G., Heck S.A., Dhingra A., et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell. 2013;12:354&#x2013;367. doi: 10.1016/j.stem.2013.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.01.008</ArticleId><ArticleId IdType="pubmed">23472874</ArticleId></ArticleIdList></Reference><Reference><Citation>Gla&#xdf; H., Pal A., Reinhardt P., Sterneckert J., Wegner F., Storch A., Hermann A. Defective mitochondrial and lysosomal trafficking in chorea-acanthocytosis is independent of Src-kinase signaling. Mol. Cell. Neurosci. 2018;92:137&#x2013;148. doi: 10.1016/j.mcn.2018.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.08.002</ArticleId><ArticleId IdType="pubmed">30081151</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P., Glatza M., Hemmer K., Tsytsyura Y., Thiel C.S., Hoing S., Moritz S., Parga J.A., Wagner L., Bruder J.M., et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS ONE. 2013;8:e59252. doi: 10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e</ArticleId><ArticleId IdType="pmc">PMC3606479</ArticleId><ArticleId IdType="pubmed">23533608</ArticleId></ArticleIdList></Reference><Reference><Citation>Gla&#xdf; H., Neumann P., Pal A., Reinhardt P., Storch A., Sterneckert J., Hermann A. Combined Dendritic and Axonal Deterioration Are Responsible for Motoneuronopathy in Patient-Derived Neuronal Cell Models of Chorea-Acanthocytosis. Int. J. Mol. Sci. 2020;21:1797. doi: 10.3390/ijms21051797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051797</ArticleId><ArticleId IdType="pmc">PMC7084777</ArticleId><ArticleId IdType="pubmed">32151030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bounedjah O., Desforges B., Wu T.D., Pioche-Durieu C., Marco S., Hamon L., Curmi P.A., Guerquin-Kern J.L., Pietrement O., Pastre D. Free mRNA in excess upon polysome dissociation is a scaffold for protein multimerization to form stress granules. Nucleic Acids Res. 2014;42:8678&#x2013;8691. doi: 10.1093/nar/gku582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku582</ArticleId><ArticleId IdType="pmc">PMC4117795</ArticleId><ArticleId IdType="pubmed">25013173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A., Kwon Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015;47:e147. doi: 10.1038/emm.2014.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.117</ArticleId><ArticleId IdType="pmc">PMC4351408</ArticleId><ArticleId IdType="pubmed">25766616</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateju D., Franzmann T.M., Patel A., Kopach A., Boczek E.E., Maharana S., Lee H.O., Carra S., Hyman A.A., Alberti S. An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function. EMBO J. 2017;36:1669&#x2013;1687. doi: 10.15252/embj.201695957.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695957</ArticleId><ArticleId IdType="pmc">PMC5470046</ArticleId><ArticleId IdType="pubmed">28377462</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallrabe H., Svindrych Z., Alam S.R., Siller K.H., Wang T., Kashatus D., Hu S., Periasamy A. Segmented cell analyses to measure redox states of autofluorescent NAD(P)H, FAD &amp; Trp in cancer cells by FLIM. Sci. Rep. 2018;8:79. doi: 10.1038/s41598-017-18634-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18634-x</ArticleId><ArticleId IdType="pmc">PMC5758727</ArticleId><ArticleId IdType="pubmed">29311591</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I., Forsgren E., Lehmann M., Andersen P.M., Br&#xe4;nnstr&#xf6;m T., Lange D.J., Synofzik M., Nordstr&#xf6;m U., Zetterstr&#xf6;m P., Marklund S.L., et al. The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tension. Acta Neuropathol. 2019;138:85&#x2013;101. doi: 10.1007/s00401-019-01986-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01986-1</ArticleId><ArticleId IdType="pmc">PMC6570705</ArticleId><ArticleId IdType="pubmed">30863976</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterstr&#xf6;m P., Andersen P.M., Br&#xe4;nnstr&#xf6;m T., Marklund S.L. Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. J. Neurochem. 2011;117:91&#x2013;99. doi: 10.1111/j.1471-4159.2011.07177.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07177.x</ArticleId><ArticleId IdType="pubmed">21226712</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund S.L., Andersen P.M., Forsgren L., Nilsson P., Ohlsson P.I., Wikander G., Oberg A. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J. Neurochem. 1997;69:675&#x2013;681. doi: 10.1046/j.1471-4159.1997.69020675.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69020675.x</ArticleId><ArticleId IdType="pubmed">9231727</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E., Haass C., Dormann D. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. FEBS J. 2013;280:4348&#x2013;4370. doi: 10.1111/febs.12287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12287</ArticleId><ArticleId IdType="pubmed">23587065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Wang S., Zheng L., Li X., Suswam E.A., Zhang X., Wheeler C.G., Nabors L.B., Filippova N., King P.H. Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): Implications for impaired post-transcriptional regulation of vascular endothelial growth factor. J. Biol. Chem. 2009;284:33989&#x2013;33998. doi: 10.1074/jbc.M109.067918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.067918</ArticleId><ArticleId IdType="pmc">PMC2797169</ArticleId><ArticleId IdType="pubmed">19805546</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Kuang L., Barnett K.R., Zhu B.Z., Shissler S.C., Korotkov K.V., Hayward L.J., Kasarskis E.J., Zhu H. ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics. Acta Neuropathol. 2016;132:563&#x2013;576. doi: 10.1007/s00401-016-1601-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1601-x</ArticleId><ArticleId IdType="pmc">PMC5023729</ArticleId><ArticleId IdType="pubmed">27481264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergh J., Zetterstrom P., Andersen P.M., Brannstrom T., Graffmo K.S., Jonsson P.A., Lang L., Danielsson J., Oliveberg M., Marklund S.L. Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping. Proc. Natl. Acad. Sci. USA. 2015;112:4489&#x2013;4494. doi: 10.1073/pnas.1419228112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1419228112</ArticleId><ArticleId IdType="pmc">PMC4394267</ArticleId><ArticleId IdType="pubmed">25802384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterstr&#xf6;m P., Graffmo K.S., Andersen P.M., Br&#xe4;nnstr&#xf6;m T., Marklund S.L. Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice. J. Biol. Chem. 2011;286:20130&#x2013;20136. doi: 10.1074/jbc.M111.218842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.218842</ArticleId><ArticleId IdType="pmc">PMC3121531</ArticleId><ArticleId IdType="pubmed">21493711</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandelin E., Nordlund A., Andersen P.M., Marklund S.S., Oliveberg M. Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins. J. Biol. Chem. 2007;282:21230&#x2013;21236. doi: 10.1074/jbc.M700765200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M700765200</ArticleId><ArticleId IdType="pubmed">17513298</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I., Forsgren E., Lange D.J., Weber M., Birve A., Synofzik M., Gilthorpe J.D., Andersen P.M., Marklund S.L. Effects of Cellular Pathway Disturbances on Misfolded Superoxide Dismutase-1 in Fibroblasts Derived from ALS Patients. PLoS ONE. 2016;11:e0150133. doi: 10.1371/journal.pone.0150133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0150133</ArticleId><ArticleId IdType="pmc">PMC4769150</ArticleId><ArticleId IdType="pubmed">26919046</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash B.P., Naumann M., Sterneckert J., Hermann A. Genome Wide Analysis Points towards Subtype-Specific Diseases in Different Genetic Forms of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020;21:6938. doi: 10.3390/ijms21186938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186938</ArticleId><ArticleId IdType="pmc">PMC7555318</ArticleId><ArticleId IdType="pubmed">32967368</ArticleId></ArticleIdList></Reference><Reference><Citation>Misgeld T., Schwarz T.L. Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture. Neuron. 2017;96:651&#x2013;666. doi: 10.1016/j.neuron.2017.09.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.09.055</ArticleId><ArticleId IdType="pmc">PMC5687842</ArticleId><ArticleId IdType="pubmed">29096078</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta R., Gillette A., Stefely M., Skala M.C. Recent innovations in fluorescence lifetime imaging microscopy for biology and medicine. J. Biomed. Opt. 2021;26:70603. doi: 10.1117/1.JBO.26.7.070603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.JBO.26.7.070603</ArticleId><ArticleId IdType="pmc">PMC8271181</ArticleId><ArticleId IdType="pubmed">34247457</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T., Cudkowicz M., Shaw P.J., Andersen P.M., Atassi N., Bucelli R.C., Genge A., Glass J., Ladha S., Ludolph A.L., et al. Phase 1&#x2013;2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2020;383:109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C., El-Khamisy S.F. Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia. Brain J. Neurol. 2018;141:1247&#x2013;1262. doi: 10.1093/brain/awy076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy076</ArticleId><ArticleId IdType="pmc">PMC5917746</ArticleId><ArticleId IdType="pubmed">29584802</ArticleId></ArticleIdList></Reference><Reference><Citation>Penndorf D., Tadic V., Witte O.W., Grosskreutz J., Kretz A. DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1G93A model of amyotrophic lateral sclerosis in vivo and in vitro. PLoS ONE. 2017;12:e0183684. doi: 10.1371/journal.pone.0183684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0183684</ArticleId><ArticleId IdType="pmc">PMC5568271</ArticleId><ArticleId IdType="pubmed">28832631</ArticleId></ArticleIdList></Reference><Reference><Citation>Bystrom R., Andersen P.M., Grobner G., Oliveberg M. SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability. J. Biol. Chem. 2010;285:19544&#x2013;19552. doi: 10.1074/jbc.M109.086074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.086074</ArticleId><ArticleId IdType="pmc">PMC2885233</ArticleId><ArticleId IdType="pubmed">20189984</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Johnson J.L., Agar N.Y., Agar J.N. Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol. 2008;6:e170. doi: 10.1371/journal.pbio.0060170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0060170</ArticleId><ArticleId IdType="pmc">PMC2486295</ArticleId><ArticleId IdType="pubmed">18666828</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 1993;261:1047&#x2013;1051. doi: 10.1126/science.8351519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler R.L., Dokholyan N.V. The complex molecular biology of amyotrophic lateral sclerosis (ALS) Prog. Mol. Biol. Transl. Sci. 2012;107:215&#x2013;262. doi: 10.1016/b978-0-12-385883-2.00002-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-385883-2.00002-3</ArticleId><ArticleId IdType="pmc">PMC3605887</ArticleId><ArticleId IdType="pubmed">22482452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Robberecht W., Van Den Bosch L. Modelling amyotrophic lateral sclerosis: Progress and possibilities. Dis. Models Mech. 2017;10:537&#x2013;549. doi: 10.1242/dmm.029058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C., Beck M.V., Griffith J.D., Deshmukh M., Dokholyan N.V. Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2018;115:4661&#x2013;4665. doi: 10.1073/pnas.1800187115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800187115</ArticleId><ArticleId IdType="pmc">PMC5939103</ArticleId><ArticleId IdType="pubmed">29666246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapasset L., Milhavet O., Prieur A., Besnard E., Babled A., Ait-Hamou N., Leschik J., Pellestor F., Ramirez J.M., De Vos J., et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 2011;25:2248&#x2013;2253. doi: 10.1101/gad.173922.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.173922.111</ArticleId><ArticleId IdType="pmc">PMC3219229</ArticleId><ArticleId IdType="pubmed">22056670</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>